ReviewAdvances in experimental medicine and biology2025
Effect of Endocrine Disruptors on Testicular Function.
Review in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Genetic, Epigenetic, and Non-Genetic Factors in Testicular Dysgenesis Syndrome: A Narrative Review.Genes · 2025Review
- Male infertility and the risk of developing prostate cancer: a bidirectional two-sample Mendelian randomization study.European journal of medical research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Several classes of exogenous chemicals interfere with the endocrine system and disrupt the normal functioning of hormones, leading to a wide range of adverse health effects. The male reproductive system is particularly vulnerable to endocrine disruption, as it involves complex interactions between endocrine, paracrine, and autocrine signals that regulate spermatogenesis and steroidogenesis within the testes. Exposure to endocrine disruptors (EDs) has been associated with reduced semen quality, including decreased sperm concentration, motility, and morphology. Some endocrine disruptors have also been linked to alterations in testosterone levels, which impact overall male reproductive health. Bisphenol A, phthalates, dioxins, polychlorinated biphenyls, organophosphate pesticides, and phytoestrogens are well-known endocrine disruptors that interfere with male reproductive functions. Furthermore, these substances have been associated with an increased risk of reproductive disorders such as cryptorchidism, hypospadias, and testicular cancer. Due to the presence of endocrine-disrupting chemicals in numerous consumer goods and personal care products, people encounter these harmful substances through ingestion, absorption, inhalation, and skin contact. However, the duration of exposure to a particular endocrine disruptor or exposure during a particular stage of development is the determining factor for testicular function. This chapter provides a comprehensive overview of the effects of endocrine disruptors on testicular function, from molecular mechanisms to clinical outcomes.
Indexed as
Identifiers
40301255What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.